Use of 81 vs 325mg of ASA in Treatment of BCVI
Clinical trial NCT06383650 · UNKNOWN
Trial details
- NCT number
- NCT06383650
- Sponsor
- London Health Sciences Centre
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-05-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.